CA2028893A1 - Morpholinoles, leur prepation et utilisation - Google Patents

Morpholinoles, leur prepation et utilisation

Info

Publication number
CA2028893A1
CA2028893A1 CA2028893A CA2028893A CA2028893A1 CA 2028893 A1 CA2028893 A1 CA 2028893A1 CA 2028893 A CA2028893 A CA 2028893A CA 2028893 A CA2028893 A CA 2028893A CA 2028893 A1 CA2028893 A1 CA 2028893A1
Authority
CA
Canada
Prior art keywords
morpholinols
carbon atoms
prepation
cycloalkyl
racemates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2028893A
Other languages
English (en)
Other versions
CA2028893C (fr
Inventor
James L. Kelley
David L. Musso
Grady E. Boswell
Barrett R. Cooper
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Publication of CA2028893A1 publication Critical patent/CA2028893A1/fr
Application granted granted Critical
Publication of CA2028893C publication Critical patent/CA2028893C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/281,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/301,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • C07D265/321,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings with oxygen atoms directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CA002028893A 1989-10-31 1990-10-30 Morpholinoles, leur prepation et utilisation Expired - Fee Related CA2028893C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB898924528A GB8924528D0 (en) 1989-10-31 1989-10-31 Heterocyclic pharmaceutical compounds,preparation and use
GB8924528.6 1989-10-31

Publications (2)

Publication Number Publication Date
CA2028893A1 true CA2028893A1 (fr) 1991-05-01
CA2028893C CA2028893C (fr) 2000-10-10

Family

ID=10665482

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002028893A Expired - Fee Related CA2028893C (fr) 1989-10-31 1990-10-30 Morpholinoles, leur prepation et utilisation

Country Status (19)

Country Link
US (1) US5104870A (fr)
EP (1) EP0426416B1 (fr)
JP (1) JP2873076B2 (fr)
AT (1) ATE101604T1 (fr)
AU (1) AU645763B2 (fr)
CA (1) CA2028893C (fr)
DE (1) DE69006682T2 (fr)
DK (1) DK0426416T3 (fr)
ES (1) ES2062406T3 (fr)
FI (1) FI94753C (fr)
GB (1) GB8924528D0 (fr)
HU (2) HU207304B (fr)
IE (1) IE66115B1 (fr)
LV (1) LV11030B (fr)
MX (1) MX9203219A (fr)
NZ (1) NZ235882A (fr)
PT (1) PT95735B (fr)
SG (1) SG28347G (fr)
ZA (1) ZA908696B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9108629D0 (en) * 1991-04-23 1991-06-12 Wellcome Found Heterocyclic pharmaceutical compounds,preparation and use
WO1999025355A1 (fr) * 1997-11-14 1999-05-27 Glaxo Group Ltd. Procede de traitement de l'accoutumance a des produits contenant de la nicotine
MA26693A1 (fr) * 1998-09-28 2004-12-20 Glaxo Group Ltd Compositions pour administration par voie buccale
AU7750100A (en) * 1999-10-13 2001-04-23 Glaxo Group Limited Method for the treatment of obesity
IL163666A0 (en) 2002-02-22 2005-12-18 New River Pharmaceuticals Inc Active agent delivery systems and methods for protecting and administering active agents
EP1968603A4 (fr) * 2006-01-03 2013-01-16 Algebra Inc Composes therapeutiques amine-arylsulfonamide conjugues
AU2010236404B2 (en) 2009-04-15 2016-11-03 Research Triangle Institute Monoamine reuptake inhibitors
WO2011146821A2 (fr) 2010-05-21 2011-11-24 Research Triangle Institute Analogues d'hydroxybupropion pour le traitement de la pharmacodépendance
AU2011255276B2 (en) 2010-05-21 2016-09-22 Research Triangle Institute Phenylmorpholines and analogues thereof
CN105949142B (zh) * 2016-05-21 2018-03-27 南华大学 具有抗抑郁活性的单一手性化合物及其制备方法和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3117967A (en) * 1962-04-02 1964-01-14 Smith Kline French Lab 2-biphenylyl-2-hydroxy-morpholinium halides
FR2553413B1 (fr) * 1983-10-17 1986-03-21 Lafon Labor Derives de 4-alkyl-2-hydroxy-3-methyl-2-phenyl-morpholine, procede de preparation et utilisation en therapeutique
GB8417170D0 (en) * 1984-07-05 1984-08-08 Wellcome Found Heterocyclic pharmaceutical compounds

Also Published As

Publication number Publication date
HU207304B (en) 1993-03-29
SG28347G (en) 1995-09-18
FI94753B (fi) 1995-07-14
DE69006682T2 (de) 1994-08-04
NZ235882A (en) 1993-05-26
JPH03206084A (ja) 1991-09-09
MX9203219A (es) 1992-07-01
DK0426416T3 (da) 1994-03-14
HU906935D0 (en) 1991-05-28
PT95735A (pt) 1991-09-13
ZA908696B (en) 1992-07-29
ATE101604T1 (de) 1994-03-15
IE903888A1 (en) 1991-05-08
GB8924528D0 (en) 1989-12-20
FI905356A0 (fi) 1990-10-30
ES2062406T3 (es) 1994-12-16
EP0426416B1 (fr) 1994-02-16
AU6563990A (en) 1991-05-09
PT95735B (pt) 1998-01-30
CA2028893C (fr) 2000-10-10
US5104870A (en) 1992-04-14
HUT57748A (en) 1991-12-30
LV11030B (en) 1996-08-20
FI94753C (fi) 1995-10-25
AU645763B2 (en) 1994-01-27
LV11030A (lv) 1996-02-20
JP2873076B2 (ja) 1999-03-24
DE69006682D1 (de) 1994-03-24
EP0426416A1 (fr) 1991-05-08
HU211304A9 (en) 1995-11-28
IE66115B1 (en) 1995-12-13

Similar Documents

Publication Publication Date Title
IE883662L (en) Compounds
ZA897660B (en) Biologically active compounds
HU9301579D0 (en) Compounds having medical effect
CA2029420A1 (fr) Compositions pharmaceutiques et methodes permettant d'inhiber la reaction de maillard
EP1473294A3 (fr) I1,3-oxathiolanes substitués avec des propriétés antivirales
CA2028893A1 (fr) Morpholinoles, leur prepation et utilisation
HU906284D0 (en) Process for the production of 24-homo-d-vitamin derivatives and medical preparations containing them as active agents
ATE110721T1 (de) 2-alkyl-3-benzoylbenzofurane und diese enthaltende pharmazeutische zusammensetzungen.
EP0259707A3 (en) Hydroxybutenolide derivatives, production and use thereof
DE3768516D1 (de) Chinonamide, deren herstellung und anwendung.
KR880007070A (ko) 백내장 치료용 약학 조성물
HUT49283A (en) Process for production of medical compositions applicable for treatment of peptical ulcer
AU4720389A (en) N-pyridinyl-9h-carbazol-9-amines, a process their preparation and their use as medicaments
GR3004095T3 (fr)

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed